Aurinia Pharmaceuticals
AUPH
AUPH
64 hedge funds and large institutions have $113M invested in Aurinia Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 14 closing their positions.
Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
17
Closed
14
Calls
$595K
Puts
$2.79M
Net Calls
-$2.2M
Net Calls Change
-$73K
Top Buyers
1 |
1
BlackRock
New York
|
$5.42M |
2 |
2
Morgan Stanley
New York
|
$3.15M |
3 |
3
D.E. Shaw & Co
New York
|
$1.21M |
4 |
PC
4
Polar Capital
London,
United Kingdom
|
$13M |
5 |
5
Goldman Sachs
New York
|
$6.45M |